MFS
XENE icon

Mirabella Financial Services’s Xenon Pharmaceuticals XENE Stock Holding History

Mirabella Financial Services’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-11,802
Closed -$6.1M – 681
2023
Q1 		$6.1M Sell
11,802
-19,657
-62% -$726K 0.92% 32
2022
Q4 		$1.24M Buy
+31,459
New +$1.15M 0.11% 126

Other funds holding XENE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Mirabella Financial Services's XENE Position: Q2 2023 in Review

Mirabella Financial Services sold out of Xenon Pharmaceuticals (XENE) in Q2 2023, closing a stake of 11,802 shares — an estimated $6.1M sold.

Mirabella Financial Services first reported a position in XENE in Q4 2022 and held it in 2 quarters. The position peaked at $6.1M in Q1 2023. 175 funds tracked by Wall St. Rank hold XENE as of Q2 2023.

  • Mirabella Financial Services reported no remaining Xenon Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • Mirabella Financial Services sold 11,802 Xenon Pharmaceuticals shares in Q2 2023, an estimated $6.1M.
  • Mirabella Financial Services first reported a position in Xenon Pharmaceuticals in Q4 2022 and held it in 2 quarters.
  • Mirabella Financial Services's Xenon Pharmaceuticals position peaked at $6.1M in Q1 2023.
  • 175 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q2 2023.

Based on Mirabella Financial Services's 13F filing for Q2 2023, filed 7 Aug 2023.